Your browser doesn't support javascript.
loading
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas.
Díaz Méndez, Ana Belén; Sacconi, Andrea; Tremante, Elisa; Lulli, Valentina; Caprara, Valentina; Rosanò, Laura; Goeman, Frauke; Carosi, Mariantonia; Di Giuliani, Marta; Vari, Giulia; Silvani, Antonio; Pollo, Bianca; Garufi, Carlo; Ramponi, Sara; Simonetti, Giorgia; Ciusani, Emilio; Mandoj, Chiara; Scalera, Stefano; Villani, Veronica; Po, Agnese; Ferretti, Elisabetta; Regazzo, Giulia; Rizzo, Maria Giulia.
Affiliation
  • Díaz Méndez AB; Department of Research, Advanced Diagnostics and Technological Innovation, Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Sacconi A; Biostatistics and Bioinformatics Unit, Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Tremante E; Department of Research, Advanced Diagnostics and Technological Innovation, Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Lulli V; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
  • Caprara V; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Rosanò L; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Goeman F; Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, Italy.
  • Carosi M; SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Di Giuliani M; Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Vari G; Department of Research, Advanced Diagnostics and Technological Innovation, Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Silvani A; Department of Research, Advanced Diagnostics and Technological Innovation, Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
  • Pollo B; PhD Program in Molecular Medicine, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Garufi C; Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Ramponi S; Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Simonetti G; Medical-Oncology Unit, San Camillo Forlanini Hospital, Rome, Italy.
  • Ciusani E; Medical-Oncology Unit, San Camillo Forlanini Hospital, Rome, Italy.
  • Mandoj C; Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Scalera S; Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Villani V; Clinical Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Po A; SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Ferretti E; PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome "Tor Vergata", Rome, Italy.
  • Regazzo G; Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Rizzo MG; Department of Experimental Medicine, Sapienza University, Rome, Italy.
J Exp Clin Cancer Res ; 42(1): 66, 2023 Mar 17.
Article in En | MEDLINE | ID: mdl-36932446

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / MicroRNAs / Circulating MicroRNA / Glioma Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: J Exp Clin Cancer Res Year: 2023 Type: Article Affiliation country: Italy

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / MicroRNAs / Circulating MicroRNA / Glioma Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: J Exp Clin Cancer Res Year: 2023 Type: Article Affiliation country: Italy